The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma
Author:
Publisher
Springer Science and Business Media LLC
Link
http://link.springer.com/content/pdf/10.1186/1465-9921-11-26
Reference31 articles.
1. Global strategy for asthma management and prevention [ http://www.ginasthma.com ]
2. Partridge MR, Molen T, Myrseth SE, Busse WW: Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006, 6:13.
3. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE: Can guideline defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004, 170:836–844.
4. Schudt C, Gantner F, Tenors H, Hatzelmann A: Therapeutic potential of selective PDE inhibitors in asthma. Pulm Pharmacol Ther 1999, 12:123–9.
5. Spina D: PDE4 inhibitors: current status. Br J Pharmacol 2008, 155:308–15.
Cited by 103 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022;Molecules;2022-08-04
2. Can Phosphodiesterase 4 Inhibitor Therapy Be Used in Respiratory Diseases Other Than Chronic Obstructive Pulmonary Disease?;Cureus;2022-07-22
3. EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research priorities;Allergy;2022-01-20
4. Phosphodiesterase‑4 inhibitors: a review of current developments (2013–2021);Expert Opinion on Therapeutic Patents;2022-01-17
5. Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases;Frontiers in Pharmacology;2021-08-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3